Ranbaxy recalls nearly 30,000 packs of allergy-relief drug in U.S

May 2, 2014 11:11 AM

14 0

MUMBAI (Reuters) - Indian drugmaker Ranbaxy Laboratories Ltd started recalling 29,790 packs of an allergy-relief medicine in the United States in February, after finding defects in the packaging, the U.S. Food and Drug Administration said.

The loratadine and pseudoephedrine sulphate extended release tablets being recalled carry an expiry date of September 2015, and were manufactured by Ranbaxy's Ohm Labs plant in New Jersey, which is the company's only facility making generics for the United States. (r.reuters.com/nuk98v)

Read more

To category page